AR and cancer: Reducing the expression of NUP210 caused a decrease in cancer cell growth and nucleus size, and therefore the application of this inhibitory mechanism in the context of AR-V7-driven CRPC tumours could result in a similar outcome and therefore represent a novel treatment strategy.